Hayrest-LS Syrup is a combination pharmaceutical formulation containing Levosalbutamol (1mg/5ml), Ambroxol (30mg/5ml), and Guaifenesin (50mg/5ml), designed for the management of respiratory conditions characterized by bronchospasm, mucus hypersecretion, and productive cough. Levosalbutamol, a selective β2-adrenergic receptor agonist, provides bronchodilation by relaxing bronchial smooth muscle, thereby alleviating bronchospasm and improving airflow in obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, enhancing mucociliary transport. Guaifenesin serves as an expectorant, promoting the hydration of respiratory tract secretions, which aids in loosening phlegm and making coughs more productive. The synergistic action of these active ingredients makes Hayrest-LS Syrup effective in relieving symptoms associated with acute and chronic bronchitis, bronchial asthma, and other respiratory tract infections with excessive mucus production. It is intended for oral administration and should be used as directed by a healthcare professional. Caution is advised in patients with hypersensitivity to any component, cardiovascular disorders, or hyperthyroidism. Adverse effects may include tremors, palpitations, gastrointestinal disturbances, and allergic reactions.